NIH-funded research R01 grant

Gut signals that protect cells and slow aging

Official title: Gut stress-induced intercellular signaling networks promoting longevity and proteostasis

Funded at University of North Carolina Charlotte · NIH-11330604 · Data updated 2026-11-12

This project looks at whether signals released by the gut can strengthen cells and help prevent age-related problems like dementia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of North Carolina Charlotte
NIH-funded
Lab location1 site (Charlotte, United States)
Project startAugust 1, 2023
Project endApril 30, 2028
Funding year2026
Award (this year)$370,490
NIH project number5R01AG082970-04
Project IDNIH-11330604 on NIH RePORTER

Who could benefit from this research

Could help

People with Alzheimer's disease, mild cognitive impairment, or older adults at risk of age-related protein-misfolding conditions would be the likely candidates for future human studies stemming from this work.

Less likely to help

Because this is early lab work in worms, patients should not expect direct or immediate treatment benefits from this project.

What this research studies

Researchers are studying how mild stress in the gut triggers signals that help other tissues maintain healthy proteins as organisms age. They use C. elegans (tiny roundworms) to reduce a gut protein called Hsp90 and observe how that change alters intercellular signaling and protein-quality control across the body. The team maps these signaling networks and identifies molecules that could later be tested in mammal or human studies. This is basic laboratory work to find mechanisms that might be targeted to promote healthier aging and protect against diseases like Alzheimer's.

Why it matters

Potential benefit: If successful, this work could point to new therapies that harness gut-derived signals to protect brain and muscle cells and slow diseases such as Alzheimer's.

How similar studies have gone: Prior animal studies have shown gut and neuronal signals can influence aging and protein homeostasis, but translating these findings into human treatments remains unproven.

Where this research is happening

  • University of North Carolina Charlotte
    Charlotte, United States
    Active

Researchers

  • Principal investigator: Van Oosten-Hawle, Patricija — University of North Carolina Charlotte
  • Study coordinator: Van Oosten-Hawle, Patricija

Related research

Other NIH-funded projects on the same topics.

  • Understanding how fetal male germ cells fix DNA breaks

    Researchers are studying how DNA damage in fetal male germ cells is repaired to keep future sperm healthy.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11627830

  • Automated single-cell heart cell measurements to test drugs

    A new automated system will quickly measure electrical signals and beating force in heart cells derived from a patient’s own stem cells to help predict drug safety.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11464806

  • Innate Immune Trigger to Boost Bone Infection Defense

    Researchers are testing a way to wake up the body's own innate immune system to fight stubborn bone infections caused by Staphylococcus aureus, aiming to help people with osteomyelitis fight bacteria more effectively.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11441932

  • Targeting Perp in pancreatic cancer and its muscle wasting

    This NIH grant explores a gene called Perp as a potential target to slow pancreatic cancer growth and reduce cachexia in patients.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11394547

  • Substance P and worsening bone infection from staph bacteria

    Aims to understand if a nerve-related molecule called substance P makes bone infection from Staphylococcus aureus worse.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11384609

  • Deciphering Pemphigus Risk Through Immune Gene Maps

    A study to map the genetic and immune signals that raise the risk of pemphigus, a rare autoimmune skin disease, in adults.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11382943

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.